Neuren raised 22m @$2 per share only 18 months ago and today they are at around $15, I am sure everyone complained of dilution. Their market cap at the time of the raise was circa 200 million and today its 1.6bn.
This is the potential return we are talking about for Dimerix....our MC is merely 40m....and 1.6bn (which with positive interim results is a very possible deal value) is 40x return.....
Ann: FSGS Study, Partnering & Commercialisation Investor Briefing, page-77
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
44.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $242.0M | |||
| Open | High | Low | Value | Volume |
| 45.0¢ | 46.5¢ | 44.0¢ | $1.428M | 3.181M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 109582 | 44.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 44.5¢ | 21213 | 1 |
View Market Depth
| Last trade - 16.10pm 09/07/2024 (20 minute delay) ? |
| DXB (ASX) Chart |